Lupin Pharmaceuticals Inc. recalls
Every recall we track for Lupin Pharmaceuticals Inc. — 123 in all, from 2013–2026 — plus the complaints and injury reports the public filed about them. 4 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Lupin Pharmaceuticals Inc. fell by more than half in 2025 (6, down from 14 in 2024). 4% rated “stop using now”.
All FDA recall records for Lupin Pharmaceuticals Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 1 | 2 | 3 |
| 2018 | 1 | 3 | 3 | 3 | 10 |
| 2019 | 0 | 0 | 17 | 6 | 23 |
| 2020 | 0 | 1 | 12 | 4 | 17 |
| 2021 | 2 | 2 | 4 | 5 | 13 |
| 2022 | 1 | 0 | 3 | 9 | 13 |
| 2023 | 0 | 0 | 4 | 1 | 5 |
| 2024 | 0 | 2 | 8 | 4 | 14 |
| 2025 | 0 | 0 | 2 | 4 | 6 |
| 2026 (to date) | 0 | 1 | 3 | 0 | 4 |
Lupin Pharmaceuticals Inc. recalls before 2017
Recalls on record by year.
Most common reasons for Lupin Pharmaceuticals Inc. recalls
What to do if you have a recalled Lupin Pharmaceuticals Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Lupin Pharmaceuticals Inc. recalls
60 shown- Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL
Lupin Pharmaceuticals recalls 0.05% Clobetasol Propionate Cream due to failed content uniformity. This may affect medication strength. Check NDC 68180-956-04 and lot numbers for affected products.
Lupin PharmaceuticalsAug 3, 2026 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL
Lupin Pharmaceuticals recalls Glucagon Emergency Kits due to a CGMP deviation in stability testing. Affected kits have specific lot numbers and expiration dates. Consumers should contact the manufacturer for details.
LupinJun 23, 2026 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b) 10 mL (NDC
Lupin Pharmaceuticals recalls prednisolone acetate ophthalmic suspension (1%) due to foreign substance presence. Rx-only medication with specific NDC codes and expiration dates affected.
Lupin PharmaceuticalsJun 4, 2026 - Use cautionDrug
Lupin Pharmaceuticals Inc. recalls Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108,
Lupin Pharmaceuticals recalls Liraglutide injection with white thread-like particles that could cause injection site reactions. Affected lots expire through 2027. Stop using and contact for replacement.
LupinApr 24, 2026 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only,
Lupin Pharmaceuticals recalls Ganirelix Acetate injection due to impurities in the product. This may affect patients using the medication. Contact the manufacturer for details.
Lupin PharmaceuticalsNov 13, 2025 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals,
Lupin Pharmaceuticals recalls 100mg sertraline tablets with defective bottle seals that may not stay closed, risking medication exposure. Affected lots: QB00865, exp. Feb 2028.
Lupin PharmaceuticalsNov 5, 2025 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls 2.5mg/10mg capsules with wrong expiry date (Feb 2027 instead of Jan 2027). Discard or contact for replacement.
LupinJul 2, 2025 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples,
Lupin Pharmaceuticals recalls 25mg clomipramine capsules due to potential impurities from degradation. Affected lots may pose safety risks. Check NDC# 68180-492-01 and lot numbers for details.
Lupin PharmaceuticalsJun 27, 2025 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals,
Lupin Pharmaceuticals recalls 20mg/12.5mg lisinopril and hydrochlorothiazide tablets due to foreign tablets found in sealed bottles. This product is for prescription use only.
Lupin PharmaceuticalsJun 20, 2025 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals,
Lupin Pharmaceuticals recalls 25mg clomipramine capsules due to impurities detected in stability testing. This may cause serious health risks. Affected products have specific lot numbers and expiration dates.
Lupin PharmaceuticalsApr 10, 2025 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals,
Lupin recalls 75 mcg levothyroxine tablets due to impurity issues detected in drug substance during stability testing. Affected units may pose safety risks if not properly handled.
LupinDec 20, 2024 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC
Lupin Pharmaceuticals recalls Ramipril 10mg capsules due to active pharmaceutical ingredient sourced from an unapproved vendor. This may pose a contamination risk. Consumers should check product details and contact Lupin for guidance.
LupinOct 23, 2024 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.,
Lupin Pharmaceuticals recalls Cefixime oral suspension (100mg/5mL) due to potential subpotency from stability testing. This may affect medication effectiveness. Contact for return instructions.
Lupin PharmaceuticalsAug 21, 2024 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for:
Lup: Cefixime oral suspension (200mg/5mL) with failed content uniformity specifications. Recalled due to potential inconsistent drug levels. No remedy stated in official notice.
LupinMay 30, 2024 - Use cautionDrug
Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls 51,006 bottles of Cefdinir for Oral Suspension USP due to lack of seal integrity in the container.
LupinMay 8, 2024 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls Cefdinir oral suspension (250 mg/5 mL) due to foreign material complaints in reconstituted bottles. This medication is prescription-only and sold in 60mL bottles.
LupinApr 24, 2024 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,
Lupin Pharmaceuticals recalls 300mg Rifampin Capsules USP 30-count bottles due to subpotent drug content. This may not provide intended treatment. Contact for details.
Lupin PharmaceuticalsMar 21, 2024 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions: Tap the
Lupin Pharmaceuticals recalls Voriconazole oral suspension (40mg/mL, orange-flavored) due to missing package insert. This may affect safe use of the medication. Check product details and contact Lupin for instructions.
Lupin PharmaceuticalsFeb 5, 2024 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,
Lupin Pharmaceuticals recalls 150mg Rifampin Capsules (30-count) due to subpotent drug and failed impurities. Rx-only product with specific batch numbers. Contact for return instructions.
Lupin PharmaceuticalsJan 5, 2024 - Use cautionDrug
Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,
Lupin Pharmaceuticals recalls one lot of Cefixime for Oral Suspension due to failed impurity specifications. Check your bottle's NDC and lot number.
Lupin PharmaceuticalsJan 3, 2024 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only,
Lupin Pharmaceuticals recalls 5mg desloratadine tablets (NDC 68180-153-01/02) due to N-Nitroso desloratadine impurity exceeding safe limits. Rx-only products with specific lot numbers and expiration dates.
Lupin PharmaceuticalsDec 20, 2023 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,
Lupin Pharmaceuticals recalls 250mg penicillamine tablets (Rx only) due to failed dissolution specifications. This may affect medication effectiveness. Contact for return instructions.
Lupin PharmaceuticalsNov 22, 2023 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals recalls 10mg Amlodipine Besylate tablets due to subpotent drug levels. Affected lots may not provide intended medication strength. No remedy specified in official notice.
Lupin PharmaceuticalsJun 27, 2023 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Tydemy (drospirenone, ethinyl estradiol and levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate
Lupin Pharmaceuticals recalls Tydemy tablets due to stability and impurity failures. Affected lots may have inactive content and impurities that could pose risks. Contact for details.
LupinJun 23, 2023 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Clobetasol propionate Cream USP, 0.05%, 45 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,
Lupin Pharmaceuticals recalls 0.05% clobetasol propionate cream tubes due to low drug potency observed in stability testing. Affected lots may not provide intended treatment.
Lupin PharmaceuticalsJan 20, 2023 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland
Lupin Pharmaceuticals recalls 300mg Rifampin capsules due to impurities detected during long-term stability testing. This may affect safety if stored beyond expiration.
LupinDec 12, 2022 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland
Lupin Pharmaceuticals recalls 20mg Quinapril tablets due to N-Nitroso impurity exceeding safety limits. Affected lots may pose health risks. Contact for return instructions.
LupinDec 7, 2022 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,
Lupin Pharmaceuticals recalls 10 mg Lisinopril tablets with a metal piece embedded in one tablet. This could cause injury if swallowed. Consumers should contact the company for details.
Lupin PharmaceuticalsSep 13, 2022 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc.,
Lupin Pharmaceuticals recalls 150mg Rifampin capsules due to impurity detected in manufacturing. This may affect safety for patients using prescription medication. Contact for details.
Lupin PharmaceuticalsJul 28, 2022 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc.,
Lupin Pharmaceuticals recalls 600mg Zileuton Extended-Release Tablets due to failed dissolution testing. Rx-only medication with specific batch numbers and expiration dates. Consumers should contact manufacturer for details.
Lupin PharmaceuticalsJun 10, 2022 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 43386-060-19
Lupin Pharmaceuticals recalls GaviLyte -C oral solution with failed stability specification. This may affect safety and requires checking product details.
Lupin PharmaceuticalsApr 27, 2022 - Stop using nowDrug
Lupin Pharmaceuticals Inc. recalls Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-03), b) 1000-count bottles (NDC#
Lupin Pharmaceuticals recalls 100mg Losartan Potassium Tablets with AZIDO impurities above safe levels. Stop using affected bottles to avoid potential health risks.
Lupin PharmaceuticalsMar 31, 2022 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals,
Lupin Pharmaceuticals recalls 5mg oxycodone tablets due to impurity detected at 18-month stability test. This may pose safety risks if stored beyond expiration.
Lupin PharmaceuticalsDec 29, 2021 - Use cautionDrug
Lupin Pharmaceuticals Inc. recalls Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454
Lupin Pharmaceuticals recalls specific lots of Gatifloxacin Ophthalmic Solution due to failed stability specifications that may alter drug concentration.
LupinDec 22, 2021 - Stop using nowDrug
Lupin Pharmaceuticals Inc. recalls Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium
Lupin Pharmaceuticals recalls Tydemy birth control tablets due to subpotent drug levels. Affected lots expire May 2022. Stop using immediately to avoid potential ineffective contraception.
Lupin PharmaceuticalsNov 19, 2021 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454
Lupin Pharmaceuticals recalls Gatifloxacin Ophthalmic Solution 0.5% 2.5mL bottles due to stability issues that could alter drug concentration. Rx only product manufactured in India with specific lot and expiration.
Lupin PharmaceuticalsOct 20, 2021 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Irbesartan and Hydrochlorothiazide Tablets USP, 300/12.5 mg a) 30 count (NDC 68180-414-06) and b) 90 count (NDC
Lupin Pharmaceuticals recalls specific lots of Irbesartan and Hydrochlorothiazide tablets due to detected impurity N-nitrosoirbesartan in the manufacturing process.
LupinOct 12, 2021 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore,
Lupin Pharmaceuticals recalls 125mg Imipramine Pamoate Capsules due to dissolution test failure at 9 months. This may affect drug stability. Check NDC# 68180-316-06 and lot H002205.
Lupin PharmaceuticalsOct 8, 2021 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals recalls Cefixime oral suspension 100mg/5mL bottles due to subpotent drug content. This means the medication may not be as effective as labeled. Consumers should contact the manufacturer for details.
Lupin PharmaceuticalsApr 29, 2021 - Stop using nowDrug
Lupin Pharmaceuticals Inc. recalls Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL
Lupin Pharmaceuticals recalls specific lots of Cefprozil for Oral Suspension USP, 250mg/5mL, due to superpotent drug hazards. Check your NDC and lot numbers.
Lupin PharmaceuticalsMar 26, 2021 - Use cautionDrug
Lupin Pharmaceuticals Inc. recalls Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured
Lupin Pharmaceuticals recalls 46,479 bottles of Oseltamivir Phosphate Oral Suspension due to out-of-specification impurity levels. Check your lot number.
LupinJan 21, 2021 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) chewable,1 mg/0.02
Lupin Pharmaceuticals recalls Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol tablets) due to failed impurities tests. These birth control tablets may contain unsafe levels of related substances. Consumers should check their product details and contact Lupin for guidance.
Lupin PharmaceuticalsJul 21, 2020 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint
Lupin Pharmaceuticals recalls 10mg Lisinopril tablets due to foreign 20mg tablets in some bottles. Affected lots may contain unsafe medication.
Lupin PharmaceuticalsJul 17, 2020 - Use cautionDrug
Lupin Pharmaceuticals Inc. recalls Metformin Hydrochloride Extended-release Tablets USP 500 mg, 100 count bottles, Rx only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls 64,344 bottles of Metformin Hydrochloride Extended-release Tablets 500 mg due to N-Nitrosodimethylamine (NDMA) impurity.
LupinJul 7, 2020 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls Cefdinir oral suspension (250mg/5mL) due to potential superpotent drug levels. This prescription medication was manufactured in India and distributed in the US. Consumers should contact Lupin for details.
LupinJul 2, 2020 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Metformin Hydrochloride Extended-release Tablets USP, 500 mg, 60 count bottle, Rx only, Manufactured for Lupin
Lupin Pharmaceuticals recalls 500mg extended-release metformin tablets due to NDMA impurity exceeding safe levels. Affected batches manufactured in India with specific batch numbers.
LupinJun 11, 2020 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD
Lupin Pharmaceuticals recalls 5mg Lisinopril tablets due to mix-up with 10mg tablets. Affected bottles may contain incorrect strength.
Lupin PharmaceuticalsMay 28, 2020 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD
Lupin Pharmaceuticals recalls 20mg Lisinopril tablets due to potential mix-up with 10mg tablets in sealed bottles. Affected products have NDC 68180-0981-03 and lot # Q000255.
Lupin PharmaceuticalsApr 20, 2020 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland
Lupin Pharmaceuticals recalls Cefixime oral suspension (100mg/5mL) due to low potency from stability testing. Affected lots may not contain full active ingredient.
LupinApr 15, 2020 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore,
Lupin Pharmaceuticals recalls 30mg Lisinopril tablets due to foreign 5mg tablets found in some bottles. This may cause incorrect dosing. Check your bottle's lot number and contact the company for details.
Lupin PharmaceuticalsApr 1, 2020 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.125mg/0.03mg, packaged in 1
Lupin Pharmaceuticals recalls birth control pills with failed content uniformity tests. These pills may not deliver the correct hormone levels, risking ineffective contraception. Consumers should contact the manufacturer for details.
Lupin PharmaceuticalsMar 9, 2020 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls 100mL Desoximetasone Topical Spray (0.25%) due to impurities. Rx-only product with specific batch numbers. Consumers should contact for details.
LupinFeb 19, 2020 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls 21mg Memantine Hydrochloride Extended Release Capsules due to failed dissolution tests. This may affect drug effectiveness. Check NDC 68180-248-06 and lot H900330 for affected products.
LupinFeb 12, 2020 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215mg/0.025 mg and 0.250 mg/0.025
Lupin Pharmaceuticals recalls specific lots of Tri-Lo-Marzia tablets due to blend uniformity issues. Check your lot number and expiration date.
LupinJan 10, 2020 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets 75mg), Rx Only,
Lupin Pharmaceuticals recalls Blisovi Fe 1.5/30 tablets due to complaints of crumbling tablets when removed from blister packs. This may affect prescription users.
Lupin PharmaceuticalsDec 26, 2019 - UnratedDrug
Lupin Pharmaceuticals Inc. recalls Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by:
Lupin Pharmaceuticals recalls 0.03% bimatoprost eye drops due to impurities in the solution. This medication is for prescription use only and may pose risks if impurities are present.
LupinDec 13, 2019 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b)
Lupin Pharmaceuticals recalls 28mg Memantine Hydrochloride Extended-release Capsules due to failed dissolution tests. Rx-only medication with specific NDC numbers and expiration dates.
Lupin PharmaceuticalsDec 10, 2019 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.,
Lupin Pharmaceuticals recalls 250mg/5mL Cefdinir oral suspension bottles due to dead ant contamination. This recall affects specific lots manufactured in Baltimore, Maryland. Consumers should contact the manufacturer for details.
Lupin PharmaceuticalsNov 1, 2019 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, 500-count bottle, Rx only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls 500-count Lisinopril and Hydrochlorothiazide tablets due to foreign tablets found in product. Consumers should check if they have the specific lot number and contact the company for details.
LupinJul 19, 2019 - Lower riskDrug
Lupin Pharmaceuticals Inc. recalls Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls Nystatin and Triamcinolone Acetonide Cream due to failed content uniformity tests at 9 months. This may affect product stability and safety for patients using prescription medication.
LupinJul 17, 2019
Lupin Pharmaceuticals Inc. recall questions
How many recalls has Lupin Pharmaceuticals Inc. had?
123 recalls from Lupin Pharmaceuticals Inc. are on record with U.S. safety agencies, from 2013–2026.
What is the most recent Lupin Pharmaceuticals Inc. recall?
Lupin Pharmaceuticals Inc. recalls Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, dated Aug 3, 2026. Every Lupin Pharmaceuticals Inc. recall is listed on this page, newest first.
Why are Lupin Pharmaceuticals Inc. products recalled?
The most common reasons on record: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits (6); CGMP Deviations: impurity N-nitrosoirbesartan detected in API (5); Presence of Foreign substance: identified as a dead ant. (3); Subpotent Drug (3).
What should I do if I have a recalled Lupin Pharmaceuticals Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Lupin Pharmaceuticals Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.